Latest News about Short/Acting Psychedelics
Recent news which mentions Short/Acting Psychedelics
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
October 13, 2023
From Benzinga
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
August 28, 2023
From Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
March 08, 2023
Tickers
DMTTF
From Benzinga
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
February 15, 2023
Tickers
DMTTF
From Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
February 01, 2023
Tickers
DMTTF
From Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
January 25, 2023
Tickers
DMTTF
From Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
From Benzinga
This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More
October 19, 2022
Tickers
DMTTF
From Benzinga